IF1 And ApoA-I Serum Concentrations, but Not HDL-cholesterol, Predict Mortality in Coronary Artery Disease Patients: The Genes Study

被引：0
|
作者：
Genoux, Annelise
Ruidavets, Jean-Bernard
Ferrieres, Jean
Bongard, Vanina
Vervueren, Paul-Louis
Combes, Guillaume
Taraszkiewicz, Dorota
Elbaz, Meyer
Perret, Bertrand
Martinez, Laurent O.
机构：
来源：
CIRCULATION | 2015年 / 132卷
关键词：
HDL; Apolipoproteins; Cardiovascular disease prevention; Biomarkers;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18834
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I
    Garin, MCB
    Moren, X
    James, RW
    JOURNAL OF LIPID RESEARCH, 2006, 47 (03) : 515 - 520
  • [2] Low HDL-cholesterol is associated with small dense LDL in coronary heart disease patients but not in patients with apoA-I defects
    Wessling, J
    Schulte, H
    Assmann, G
    Miccoli, R
    Navalesi, R
    vonEckardstein, A
    ATHEROSCLEROSIS, 1997, 129 (01) : 33 - 33
  • [3] A new APOA1 mutation with severe HDL-cholesterol deficiency and premature coronary artery disease
    Esperon, Patricia
    Raggio, Victor
    Stoll, Mario
    Vital, Marcelo
    Esperon, Patricia
    Alallon, Walter
    CLINICA CHIMICA ACTA, 2008, 388 (1-2) : 222 - 224
  • [4] Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients
    S. S. Soedamah-Muthu
    H. M. Colhoun
    M.-R. Taskinen
    B. Idzior-Walus
    J. H. Fuller
    Diabetologia, 2000, 43 : 1353 - 1359
  • [5] Differences in HDL-cholesterol:apoA-I plus apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients
    Soedamah-Muthu, SS
    Colhoun, HM
    Taskinen, MR
    Idzior-Walus, B
    Fuller, JH
    DIABETOLOGIA, 2000, 43 (11) : 1353 - 1359
  • [6] HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease
    Kuchta, Agnieszka
    Strzelecki, Adrian
    Cwiklinska, Agnieszka
    Gruchala, Marcin
    Zdrojewski, Zbigniew
    Kortas-Stempak, Barbara
    Wieczorek, Ewa
    Gliwinska, Anna
    Dabkowski, Iamil
    Jankowski, Maciej
    JOURNAL OF CARDIOLOGY, 2017, 69 (3-4) : 523 - 528
  • [7] Fasting glucose and HDL-cholesterol predict coronary artery disease mortality in a multi-ethnic US population
    Sierra-Johnson, J.
    Hamsten, A.
    Romero-Corral, A.
    Ryden, L.
    Ohrvik, J.
    EUROPEAN HEART JOURNAL, 2008, 29 : 596 - 596
  • [8] Development of two site APOA-I/HDL immunoassay for estimation of risk of coronary artery disease
    Negi, P.
    Heikkila, T.
    Lankinen, R.
    Vuorenpaa, K.
    Jauhiainen, M.
    Lamminmaki, U.
    Lovgren, J.
    Pettersson, K.
    CLINICA CHIMICA ACTA, 2019, 493 : S10 - S10
  • [9] Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study
    Genoux, Annelise
    Ruidavets, Jean-Bernard
    Ferrieres, Jean
    Combes, Guillaume
    Lichtenstein, Laeticia
    Pons, Veronique
    Laffargue, Muriel
    Taraszkiewicz, Dorota
    Carrie, Didier
    Elbaz, Meyer
    Perret, Bertrand
    Martinez, Laurent O.
    JOURNAL OF LIPID RESEARCH, 2013, 54 (09) : 2550 - 2558
  • [10] Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease
    Akboga, M.
    Balci, K.
    Maden, O.
    Ertem, A.
    Kirbas, O.
    Yayla, C.
    Acar, B.
    Aras, D.
    Kisacik, H.
    Aydogdu, S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 170 - 170
12345